I-Liraglutide CAS:204656-20-2 Umkhiqizi Supplier
I-Liraglutide iwuhlobo olusha lomuthi we-hypoglycemic owenza kusebenze i-protein kinase ecushwe yi-AMP ngaleyo ndlela ithuthukise ukuzwela kwe-insulin.Ayinawo nje umphumela obalulekile we-hypoglycemic, kodwa futhi inemisebenzi yokwehlisa isisindo, ukunciphisa umfutho wegazi, nokuthuthukiswa kwephrofayili ye-lipid yegazi.I-Liraglutide, i-glucagon-like peptide-1 (GLP-1) receptor agonist receptor agonists, ibambezela ukuphuma kwesisu. , kwandisa ukusutha, futhi kunciphisa ukudla kwesiguli, kuyilapho kunciphisa isifiso sobuchopho sokudla futhi kuvumela umzimba ukuba Ukwenyuka kwezindleko zamandla kudlala indima ekunciphiseni isisindo;ivimbela isibindi ekukhiqizeni i-glucose eningi futhi ikhuthaza ama-pancreas ukuthi akhiqize i-insulin eyengeziwe ukuze ehlise ushukela wegazi;ngaphezu kwalokho, i-liraglutide nayo inezinzuzo zenhliziyo nokuvikelwa kwezinso.
Ukwakheka | I-C172H265N43O51 |
Isivivinyo | 99% |
Ukubukeka | Impushana emhlophe |
Inombolo ye-CAS. | 204656-20-2 |
Ukupakisha | 25KG |
I-Shelf Life | iminyaka engu-2 |
Isitoreji | Gcina endaweni epholile neyomile |
Isitifiketi | ISO. |